Axel Bolte

Track

Insider profile

Currently holds positions in Inozyme Pharma Inc and Iveric Bio Inc

Positions

Position Company Period
Chief Executive Officer, Co-Founder Inozyme Pharma Inc None -
Independent Director Iveric Bio Inc Aug. 1, 2007 -
Independent Director Allena Pharmaceuticals Inc Jan. 1, 2014 - June 5, 2019
Member of the Supervisory Board Nabriva Therapeutics PLC June 1, 2017 - Aug. 1, 2018
Independent Deputy Chairman of the Supervisory Board Nabriva Therapeutics PLC Jan. 1, 2013 - June 1, 2017
Independent Director PTC Therapeutics Inc Dec. 1, 2003 - June 10, 2014
Axel Bolte's trades of Inozyme Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
273.55
Quantity 17,522 -13.3%
Value US$1,007,756
Transaction date
Sale
Price
376.71
Quantity 9,513 +25.6%
Value US$4,658,480
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-20 2022-04-19
B Purchase
17,522 -13.3%
273.55
US$1,007,756 		17,522 -13.3% 273.55 US$1,007,756
2021-06-25 2021-06-24
S Sale
9,513 +25.6%
376.71
US$4,658,480 		9,513 +25.6% 376.71 US$4,658,480